Literature DB >> 8424268

Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi.

M D Appleman1, I A Shulman, S Saxena, L V Kirchhoff.   

Abstract

Trypanosoma cruzi is the protozoan parasite that causes American trypanosomiasis (Chagas' disease). Chagas' disease is endemic in Latin America. The infection is usually seen in poor people who live in rural areas in substandard housing, where they are bitten by infected reduviid bugs. Transmission also can occur by blood transfusion. Infected individuals who immigrate to the United States might donate blood if they are asymptomatic and unaware of their infection. This study evaluated the usefulness of a questionnaire for identifying T. cruzi-infected individuals among prospective blood donors who met all American Association of Blood Banks, Food and Drug Administration, and State of California criteria for donor eligibility. Seventy-two of 3492 otherwise eligible donors were disqualified because of their answers on the questionnaire. Forty-five of these 72 agreed to be tested serologically, and 2 were positive for T. cruzi antibodies. One of six autologous blood donors tested also was positive for T. cruzi antibodies. We conclude that the questionnaire selected a subgroup of Latin Americans at high risk for T. cruzi infection. The deferral of these high-risk individuals clearly reduced the risk of transmission of T. cruzi by transfusion, without intolerably decreasing the supply of donated blood.

Entities:  

Mesh:

Year:  1993        PMID: 8424268     DOI: 10.1046/j.1537-2995.1993.33193142312.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

1.  Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits.

Authors:  D A Leiby; S Wendel; D T Takaoka; R M Fachini; L C Oliveira; M A Tibbals
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Authors:  Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

3.  Dealing with initial inconclusive serological results for chronic Chagas disease in clinical practice.

Authors:  J S Lapa; R M Saraiva; A M Hasslocher-Moreno; I Georg; A S Souza; S S Xavier; P E A A do Brasil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-08       Impact factor: 3.267

4.  Prevalence and epidemiological significance of Trypanosoma cruzi infection among Latin American immigrants in Berlin, Germany.

Authors:  M Frank; B Hegenscheid; K Janitschke; T Weinke
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

5.  Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis.

Authors:  H A Avila; J B Pereira; O Thiemann; E De Paiva; W DeGrave; C M Morel; L Simpson
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

Review 6.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

7.  Changing Epidemiology and Approaches to Therapy for Chagas Disease.

Authors:  Louis V. Kirchhoff
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

8.  Effectiveness of blood donor questionnaire directed at risk factor for transfusion transmitted infections in Pakistani population.

Authors:  Nuzhat Salamat
Journal:  Asian J Transfus Sci       Date:  2012-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.